Mental Health

Mini-Mental State Examination (MMSE) {OMAMLC}

Item Score
Orientation 10
Memory :: registration 3
Attention 5
Memory :: recall 3
Language 8
Construction 1

Confusion Assessment Method (CAM)

  • Consciousness
  • Attention
  • Mental status
  • Thinking

Psychiatric Disorders

Neurodevelopmental Disorders

  • Intellectual disability
  • Communication disorder
  • Autism spectrum disorder
  • Attention-deficit hyperactivity disorder (ADHD)
  • Motor disorder
    • Tic disorder
    • Tourette syndrome

Neurocognitive Disorders

  • Delirium
  • Dementia due to Parkinson disease
  • Dementia due to Alzheimer disease
  • Dementia due to Pick disease
  • Dementia due to prion disease
  • Dementia due to Huntington disease

Personality Disorders

  • Cluster A: Paranoid & Schizoid & Schizotypal
  • Cluster B: Antisocial & Borderline & Histrionic & Narcissistic
  • Cluster C: Avoidant & Obsessive-compulsive & Dependent

Psychotic Disorders

  • Delusional disorder
  • Brief psychotic disorder: < 1 month
  • Schizophreniform disorder: 1 ~ 6 months
  • Schizophrenia: > 6 months
  • Schizoaffective disorder

Mood Disorders

  • Bipolar I/II disorder
  • Cyclothymia: > 2 years
  • Major depressive disorder: > 2 weeks
  • Persistent depressive disorder [Dysthymia]: > 2 years
  • Seasonal affective disorder (SAD)

Anxiety Disorders

  • Adjustment disorder: < 6 months
  • Generalized anxiety disorder: > 6 months
  • Acute stress disorder: < 1 month
  • Post-traumatic stress disorder (PTSD): > 1 month
  • Panic disorder: > 1 month
  • Phobias: > 6 months
    • Agoraphobia
    • Social anxiety disorder
    • Specific phobias
  • Obsessive-compulsive disorder (OCD)
    • Body dysmorphic disorder
  • Separation anxiety disorder
  • Selective mutism

Dissociative Disorders

  • Dissociative amnesia & fugue
  • Dissociative identity disorder
  • Depersonalization & Derealization disorder

Somatic Disorders

  • Malingering
  • Factitious disorder
  • Somatic symptom disorder
  • Conversion disorder
  • Illness anxiety disorder

Feeding & Eating Disorders

  • Pica
  • Anorexia nervosa
  • Bulimia nervosa

Sexual Dysfunction

  • Sexual arousal disorder
  • Sexual desire disorder
  • Sexual pain disorder
  • Orgasmic disorder

Sleep-wake Disorders

  • Insomnia
  • Hypersomnia
  • Narcolepsy
  • Nightmare disorder
  • Sleepwalking disorder
  • Sleep terror disorder
  • Restless legs disorder
  • Sleep apnea

Disruptive Behavior Disorders

  • Oppositional defiant disorder
  • Intermittent explosive disorder
  • Conduct disorder

Symptom Duration Required for Diagnosis

Types of Delusions

  • Delusion of control
  • Delusion of guilt
  • Delusion of reference
  • Erotomanic delusion
  • Grandiose delusion
  • Jealous delusion
  • Persecutory delusion
  • Somatic delusion

Presentation of Schizophrenia

  • Delusions
  • Hallucinations
  • Speech disturbances
  • Catatonia
  • Negative symptoms

Antipsychotics

1° [Typical] Antipsychotics

High Potency

  • Haloperidol
  • Trifluoperazine
  • Fluphenazine

Low Potency

  • Chlorpromazine
  • Thioridazine

2° [Atypical] Antipsychotics

  • Aripiprazole
  • Clozapine
  • Olanzapine
  • Quetiapine
  • Risperidone
  • Ziprasidone

Side Effects of Antipsychotics

  • Anticholinergic symptoms
  • Antiadrenergic symptoms
  • Antihistamine symptoms
  • Cardiac :: QT prolongation
  • Extrapyramidal symptoms (EPS)
  • Endocrine :: hyperprolactinemia
  • Hematologic :: agranulocytosis
  • Metabolic syndrome
  • Neuroleptic malignant syndrome (NMS)

Extrapyramidal Symptoms (EPS)

Onset Symptoms Treatment
4 hours Dystonia 1° Antihistamines
M antagonists
4 days Bradykinesia 1° Antihistamines
M antagonists
4 weeks Akathisia β antagonists
Benzodiazepines
4 months Tardive dyskinesia VMAT2 inhibitors

Presentation of Neuroleptic Malignant Syndrome (NMS) {FEVER}

  • Fever
  • Encephalopathy
  • Vitals unstable
  • Enzyme elevation :: creatine kinase (CK)
  • Rigidity

Medications for Neuroleptic Malignant Syndrome (NMS)

Mechanism Medication
Ca channel blockers Dantrolene
D2 agonists Bromocriptine
NMDA antagonists Amantadine
GABAA agonists Benzodiazepines

Presentation of Major Depressive Episode {SIG-E-CAPS}

  • Sleep disturbances :: insomnia & hypersomnia
  • Interest
  • Guilt
  • Energy
  • Concentration
  • Appetite changes :: anorexia & hyperphagia
  • Psychomotor agitation & retardation
  • Suicidal ideation

Effects of Depression on Sleep-Wake Cycle

  • ↓ REM latency
  • ↑ Total REM sleep

Antidepressants

Mechanism Medication
Reuptake inhibitors TCAs
SSRIs
SNRIs
  NDRI ::
Bupropion
MAO inhibitors Tranylcypromine
Phenelzine
Isocarboxazid
Selegiline
α2 antagonists Mirtazapine
5-HT modulators Trazodone

Side Effects of Antidepressants

  • Anticholinergic symptoms
  • Antiadrenergic symptoms
  • Antihistamine symptoms
  • Cardiac :: QT prolongation
  • Serotonin syndrome

Presentation of Serotonin Syndrome

  • Altered mental status (AMS)
  • Hyperthermia
  • Cardiovascular collapse
  • Hyperreflexia
  • Myoclonus

Presentation of Manic Episode {DIG-FAST}

  • Distractibility
  • Irresponsibility
  • Grandiosity
  • Flight of ideas
  • Agitation
  • Sleep deprivation
  • Talkativeness

Medications for Bipolar Disorder

Mechanism Medication
Mood stabilizer Lithium
D2 antagonists 2° Antipsychotics
Na channel blockers Valproate
Carbamazepine
Lamotrigine

Clinical Features of Anxiety Disorders

Disorder Preceding Stressor Identifiable Trigger Duration
Adjustment disorder + - < 6 months
Generalized anxiety disorder ± - > 6 months
Acute stress disorder + + < 1 month
Post-traumatic stress disorder (PTSD) + + > 1 month
Panic disorder - ± > 1 month
Phobias - + > 6 months

Anxiolytics

Mechanism Medication
Reuptake inhibitors TCAs
SSRIs
SNRIs
MAO inhibitors Tranylcypromine
Phenelzine
Isocarboxazid
Selegiline
β antagonists Propranolol
5-HT1 agonists Buspirone
GABAA agonists Benzodiazepines

Medications for Insomnia

Mechanism Medication
5-HT modulators Trazodone
GABAA agonists Benzodiazepines
  Zolpidem
Zaleplon
Eszopiclone

Medications for OCD

Mechanism Medication
Reuptake inhibitors TCAs
SSRIs
SNRIs

Medications for ADHD

Mechanism Medication
Reuptake inhibitors NRI ::
Atomoxetine
  NDRI ::
Methylphenidate

Medications for Tourette Syndrome

Mechanism Medication
VMAT2 inhibitors Tetrabenazine
Valbenazine
α2 agonists Clonidine
Guanfacine
D2 antagonists Antipsychotics

Clinical Features of Somatic Disorders

Disorder Symptoms Motivation
Malingering Conscious Conscious
Factitious disorder Conscious Unconscious
Somatic symptom Unconscious Unconscious